CNAM
IART icon

Campbell Newman Asset Management’s Integra LifeSciences IART Stock Holding History

Campbell Newman Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,061
Closed -$612K – 113
2023
Q4 		$612K Sell
14,061
-208
-1% -$8.19K 0.05% 99
2023
Q3 		$545K Sell
14,269
-260
-2% -$10.9K 0.05% 102
2023
Q2 		$598K Buy
14,529
+314
+2% +$15.1K 0.05% 100
2023
Q1 		$816K Buy
14,215
+127
+0.9% +$7.16K 0.08% 94
2022
Q4 		$790K Buy
14,088
+447
+3% +$22.8K 0.08% 93
2022
Q3 		$578K Buy
13,641
+324
+2% +$16.6K 0.07% 95
2022
Q2 		$720K Buy
13,317
+574
+5% +$34.5K 0.08% 94
2022
Q1 		$819K Buy
12,743
+243
+2% +$16K 0.08% 94
2021
Q4 		$837K Buy
12,500
+333
+3% +$22.5K 0.07% 96
2021
Q3 		$833K Buy
12,167
+634
+5% +$44.8K 0.09% 94
2021
Q2 		$787K Buy
11,533
+584
+5% +$41.3K 0.08% 99
2021
Q1 		$756K Buy
10,949
+506
+5% +$34.3K 0.08% 99
2020
Q4 		$678K Buy
10,443
+781
+8% +$42K 0.08% 98
2020
Q3 		$456K Buy
9,662
+174
+2% +$8.28K 0.06% 107
2020
Q2 		$446K Buy
9,488
+85
+0.9% +$4.18K 0.06% 102
2020
Q1 		$420K Sell
9,403
-518
-5% -$27.2K 0.07% 97
2019
Q4 		$578K Buy
9,921
+65
+0.7% +$3.87K 0.08% 101
2019
Q3 		$592K Sell
9,856
-80
-0.8% -$4.77K 0.08% 98
2019
Q2 		$555K Buy
9,936
+658
+7% +$33.9K 0.08% 103
2019
Q1 		$517K Buy
9,278
+218
+2% +$11.1K 0.08% 103
2018
Q4 		$409K Buy
9,060
+944
+12% +$51.8K 0.07% 107
2018
Q3 		$535K Buy
8,116
+421
+5% +$26.2K 0.08% 105
2018
Q2 		$496K Buy
7,695
+354
+5% +$21.9K 0.08% 102
2018
Q1 		$406K Buy
7,341
+377
+5% +$19.8K 0.07% 108
2017
Q4 		$333K Buy
6,964
+1,234
+22% +$60.4K 0.06% 112
2017
Q3 		$289K Buy
5,730
+739
+15% +$38K 0.05% 111
2017
Q2 		$272K Buy
+4,991
New +$238K 0.05% 108

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Campbell Newman Asset Management's IART Position: Q1 2024 in Review

Campbell Newman Asset Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 14,061 shares — an estimated $612K sold.

Campbell Newman Asset Management first reported a position in IART in Q2 2017 and held it in 27 quarters. The position peaked at $837K in Q4 2021. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Campbell Newman Asset Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Campbell Newman Asset Management sold 14,061 Integra LifeSciences shares in Q1 2024, an estimated $612K.
  • Campbell Newman Asset Management first reported a position in Integra LifeSciences in Q2 2017 and held it in 27 quarters.
  • Campbell Newman Asset Management's Integra LifeSciences position peaked at $837K in Q4 2021.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Campbell Newman Asset Management's 13F filing for Q1 2024, filed 16 Apr 2024.